Dr. Martens plc
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Dr. Martens plc's yearly results (2023–2026), compared with Consumer Cyclical companies in United Kingdom. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every £100 the company owns, £69 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 90% of Consumer Cyclical companies in United Kingdom.
- Profit Cash Ratio: Over the last 3 years, every £100 of reported profit came with £520 of operating cash. Higher than 89% of Consumer Cyclical companies in United Kingdom.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 87% of Consumer Cyclical companies in United Kingdom.
Where £100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
£520Over the last 3 years, every £100 of reported profit came with £520 of operating cash.
Higher than 89% of Consumer Cyclical companies in United Kingdom.
Self-Funding Ratio
8.6×Over the last 3 years its own operating cash covered its investment spending (capex) 8.6 times.
Higher than 75% of Consumer Cyclical companies in United Kingdom.
Cash Locked Ratio
£21For every £100 of sales, £21 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against £25 tied up three years earlier.
More money tied up than 63% of Consumer Cyclical companies in United Kingdom.
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 87% of Consumer Cyclical companies in United Kingdom.
Growth Efficiency Ratio
—Sales fell 24%
Sales fell 24% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-24% / -12%In 3 years sales changed by -24% while total assets changed by -12%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
68.0×Debt due within a year is covered 68.0 times by its yearly operating cash.
Higher than 73% of Consumer Cyclical companies in United Kingdom.
Cash Cushion Ratio
−34%Debt, after subtracting cash, equals 34% of its market value (net debt).
Lower than 68% of Consumer Cyclical companies in United Kingdom.
Tangible Assets Ratio
69%Of every £100 the company owns, £69 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 90% of Consumer Cyclical companies in United Kingdom.
Tangible Net Worth Ratio
25%Of every £100 of net worth, £25 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 82% of Consumer Cyclical companies in United Kingdom.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Dr. Martens plc owes £0.59 for every £1 it owns. Net profit rose 429% in the year to Mar 2026, and shrank 43% a year on average over 3 years.
Compared with Consumer Cyclical companies in United Kingdom · latest annual results Mar 2026.
P/E ratio
33.0Investors pay £33.0 for every £1 of Dr. Martens plc's yearly profit, higher than 77% of Consumer Cyclical companies in United Kingdom.
P/B ratio
1.75The share price is 1.75 times Dr. Martens plc's book value per share, higher than 54% of Consumer Cyclical companies in United Kingdom.
Market cap
£631 MThe total market value of all of Dr. Martens plc's shares at today's price (share price × number of shares), smaller than 97% of Consumer Cyclical companies in United Kingdom. PosiCap size class: Mini Cap.
Net worth (book value)
£362 MWhat Dr. Martens plc would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
£0.38Net worth divided by the number of shares. The share price of £0.66 is 1.7 times this, which is the P/B above.
Return on equity (ROE)
6.5%Dr. Martens plc earned 6.5% on its shareholders' money over the last year, lower than 68% of Consumer Cyclical companies in United Kingdom.
Owes vs Owns
0.59×Dr. Martens plc owes £0.59 for every £1 it owns (moderate), higher than 50% of Consumer Cyclical companies in United Kingdom.
Dividend yield
3.86%Dr. Martens plc pays 3.86% of its share price as dividends a year, higher than 81% of dividend-paying Consumer Cyclical companies in United Kingdom.
Revenue growth
-3%Revenue fell 3% in the year to Mar 2026, and shrank 9% a year on average over 3 years.
Profit growth
+429%Net profit rose 429% in the year to Mar 2026, and shrank 43% a year on average over 3 years.
Profit margin
3.1%Dr. Martens plc keeps £3 of every £100 of revenue as net profit.
Cash quality
6.0×Cash from Dr. Martens plc's business was 6.0× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
2.3×Dr. Martens plc's operating profit covered its interest costs 2.3 times in the year to Mar 2026.
Cash vs debt
Net debtDr. Martens plc had £213 M more debt than cash (net debt) at Mar 2026.
Questions
What is Dr. Martens plc's P/E ratio?
Investors pay £33.0 for every £1 of Dr. Martens plc's yearly profit, higher than 77% of Consumer Cyclical companies in United Kingdom.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Dr. Martens plc: £631 M ÷ £362 M (31 Mar 2026) = 1.7.
What is Dr. Martens plc's return on equity?
Dr. Martens plc earned 6.5% on its shareholders' money over the last year, lower than 68% of Consumer Cyclical companies in United Kingdom.
How much does Dr. Martens plc owe compared with what it owns?
Dr. Martens plc owes £0.59 for every £1 it owns (moderate), higher than 50% of Consumer Cyclical companies in United Kingdom.
Does Dr. Martens plc pay a dividend?
Yes. Dr. Martens plc pays 3.86% of its share price as dividends a year, higher than 81% of dividend-paying Consumer Cyclical companies in United Kingdom.
Is Dr. Martens plc's revenue growing?
Revenue fell 3% in the year to Mar 2026, and shrank 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.